Search

The COVID-19 has exacted a significant toll on the global economy. This new analysis looks at the economic impacts in PEPFAR countries finding that these countries generally fared worse than their economic and regional peers. In addition, the projected economic growth in these countries remains below pre-pandemic levels.

This issue brief assesses how the HIV policy landscapes in PEPFAR countries compare to international standards and recommendations. Additionally, we look at the HIV policy landscapes in PEPFAR countries as compared to peer countries. These comparisons are done at the overall, category, and policy indicator level.

This brief provides an overview of recent data on cancer incidence and mortality, risk factors, screening, treatment, and outcomes by race and ethnicity. Racial disparities in cancer incidence and outcomes are well-documented, with research showing that they are driven by a combination of structural, economic, and socioenvironmental inequities that are rooted in racism and discrimination, as well as genetic and hereditary factors that may be influenced by the environment.

6 in 10 Who Tried to Purchase an At-Home Test and a Third Who Sought an In-Person Test Say It Was Difficult to Find, Though Most Were Eventually Able to Get a Test Black and Hispanic Adults are More Likely Than White Adults to Worry About Omicron’s Effects, Including Becoming…

As part of an effort to promote equitable access to tests, the Biden administration launched a testing supply program that has set aside 25 million rapid at-home self-test kits for distribution by community health centers. Under the program, health centers will be distributing self-tests to patients and community members, with a focus on populations at greatest risk from adverse outcomes related to COVID-19.

The Biden Administration’s requirement for private insurers to cover the cost of at-home rapid COVID-19 tests for their enrollees does not apply to Medicare. Medicare Advantage plans (offered by private insurers) have the option to cover at-home tests but are not required to do so. This policy watch examines whether some of the largest private Medicare Advantage plans are covering the cost of at-home rapid tests for COVID-19.

Jan. 27, 2022 — SAN FRANCISCO and SIOUX FALLS, S.D. — KFF is expanding its KHN (Kaiser Health News) operation by establishing a rural health reporting desk supported by a $3.9 million grant from The Leona M. and Harry B. Helmsley Charitable Trust. KFF will expand KHN’s editorial staff and…

Twenty drugs and dozens of insulin products used by 8.5 million Medicare beneficiaries would be subject to government drug price negotiation if the Build Back Better Act (BBBA) were enacted and fully implemented in 2022, according to a new KFF analysis. The 20 drugs include 18 drugs available to beneficiaries…

This report shows that 42% of all adults have received a COVID-19 booster, including about 70% of those who are likely booster-eligible. More than three quarters (77%) have received at least one dose of a COVID-19 vaccine. The poll also explores the public’s experiences getting at-home and in-person COVID-19 tests and other issues.

With the COVID-19 pandemic impacting communities of color disproportionately in their health and economic well-being, long-term racial and ethnic disparities have received growing attention. But these inequities in our health system are not new and are a part of larger issues of systemic racism. An updated KFF chart pack analyzes…